Large-scale testing (Phase 3)Study completedNCT00056550
What this trial is testing
Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations.
Who this might be right for
Antithrombin Deficiency, Congenital
rEVO Biologics 14